64 related articles for article (PubMed ID: 7581106)
1. Analysis of peripheral blood progenitor cells demonstrates limitations of minimal residual disease diagnosis in a case of acute promyelocytic leukemia.
Karlic HI; Mühlberger H; Pavlova BG; Pfeilstöcker M; Salamon J; Pittermann E; Heinz R; Koller E
Bone Marrow Transplant; 1995 Jun; 15(6):999-1000. PubMed ID: 7581106
[TBL] [Abstract][Full Text] [Related]
2. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
Gau JP; Young JH; Lin TH; Yang YS
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
[TBL] [Abstract][Full Text] [Related]
4. [Monitoring of minimal residual disease in patients with acute promyelocytic leukemia].
Shuravina EN; Parovichnikova EN; Demidova IA; Misiurin AV; Isaev VG; Ol'shanskaia IuV; Savchenko VG
Ter Arkh; 2006; 78(7):25-31. PubMed ID: 16944747
[TBL] [Abstract][Full Text] [Related]
5. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
[TBL] [Abstract][Full Text] [Related]
6. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
[TBL] [Abstract][Full Text] [Related]
7. Detection of minimal residual disease by reverse transcriptase polymerase chain reaction for the PML/RAR alpha fusion mRNA: a study in patients with acute promyelocytic leukemia following peripheral stem cell transplantation.
Takatsuki H; Umemura T; Sadamura S; Yamashita S; Goto T; Abe Y; Yufu Y; Inaba S; Nishimura J; Nawata H
Leukemia; 1995 May; 9(5):889-92. PubMed ID: 7539517
[TBL] [Abstract][Full Text] [Related]
8. PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome.
Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239
[TBL] [Abstract][Full Text] [Related]
9. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia.
Diverio D; Riccioni R; Mandelli F; Lo Coco F
Haematologica; 1995; 80(2):155-60. PubMed ID: 7628753
[TBL] [Abstract][Full Text] [Related]
10. Assessment of residual disease in acute leukemia by means of polymerase chain reaction.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Pérez-Romano B; Ruiz-Argüelles A; Ramírez-Cisneros FJ; López-Martínez B; López-Tapia JD; Rivadeneyra-Espinoza L
Rev Invest Clin; 2000; 52(2):118-24. PubMed ID: 10846434
[TBL] [Abstract][Full Text] [Related]
11. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
[TBL] [Abstract][Full Text] [Related]
12. Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level.
Martinelli G; Ottaviani E; Visani G; Testoni N; Montefusco V; Tura S
Haematologica; 1998 Sep; 83(9):860-3. PubMed ID: 9825588
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
[TBL] [Abstract][Full Text] [Related]
14. Absence of detectable PML-RAR alpha fusion transcripts in long-term remission patients after BMT for acute promyelocytic leukemia.
Román J; Martín C; Torres A; Jiménez MA; Andrés P; Flores R; de la Torre MJ; Sánchez J; Serrano J; Falcón M
Bone Marrow Transplant; 1997 Apr; 19(7):679-83. PubMed ID: 9156244
[TBL] [Abstract][Full Text] [Related]
15. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
Moos M; Schulz R; Cremer F; Sucker C; Schmohl D; Döhner H; Goldschmidt H; Haas R; Hunstein W
Stem Cells; 1995 Dec; 13 Suppl 3():42-51. PubMed ID: 8747988
[TBL] [Abstract][Full Text] [Related]
16. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
[TBL] [Abstract][Full Text] [Related]
17. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia.
Turhan AG; Lemoine FM; Debert C; Bonnet ML; Baillou C; Picard F; Macintyre EA; Varet B
Blood; 1995 Apr; 85(8):2154-61. PubMed ID: 7536493
[TBL] [Abstract][Full Text] [Related]
18. [Quantification of PML/RAR alpha fusion gene transcripts in patients with acute promyelocytic leukemia by using real-time quantitative PCR].
Lin J; Han LX; Qian J; Wang YL; Qian Z; Yang XF; Sheng XJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):319-21. PubMed ID: 18543226
[TBL] [Abstract][Full Text] [Related]
19. Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remission.
Ottaviani E; Martinelli G; Testoni N; Visani G; Tani M; Tura S
Haematologica; 1998 Nov; 83(11):1051-5. PubMed ID: 9864933
[TBL] [Abstract][Full Text] [Related]
20. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
